Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

Shenzhen YHLO Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Market Capitalization	8,577	9,010	12,993	11,142	13,993	-
Market Cap Growth	-8.91%	-30.65%	16.62%	-20.38%	-	-
Enterprise Value	8,866	9,226	12,949	10,739	13,697	-
Last Close Price	15.01	15.58	22.26	18.68	23.15	-
PE Ratio	57.56	29.88	36.60	11.01	68.34	-
Forward PE	27.59	21.94	21.94	17.99	34.64	-
PS Ratio	4.50	4.48	6.33	2.80	11.88	-
PB Ratio	3.25	3.34	5.13	4.56	9.24	-
P/TBV Ratio	3.39	3.51	5.49	5.06	9.84	-
P/FCF Ratio	113.53	-	-	10.95	-	-
P/OCF Ratio	30.97	17.00	-	7.04	53.90	-
EV/Sales Ratio	4.66	4.59	6.31	2.70	11.63	-
EV/EBITDA Ratio	16.74	16.05	29.37	8.32	44.16	-
EV/EBIT Ratio	35.92	27.50	51.46	9.37	64.96	-
EV/FCF Ratio	117.36	-	-	10.55	-	-
Debt / Equity Ratio	0.37	0.34	0.22	0.19	0.15	0.41
Debt / EBITDA Ratio	1.86	1.56	1.24	0.37	0.75	0.95
Debt / FCF Ratio	13.02	-	-	0.47	-	3.40
Asset Turnover	0.46	0.49	0.51	1.25	0.68	0.83
Inventory Turnover	1.11	1.10	1.58	4.15	1.60	1.53
Quick Ratio	1.30	1.22	1.39	1.20	1.51	0.88
Current Ratio	2.07	1.90	2.20	1.63	2.30	1.53
Return on Equity (ROE)	5.12%	10.40%	11.22%	51.59%	17.89%	30.99%
Return on Assets (ROA)	3.71%	5.10%	3.92%	22.55%	7.61%	13.71%
Return on Invested Capital (ROIC)	7.21%	11.12%	10.88%	72.04%	17.98%	29.09%
Return on Capital Employed (ROCE)	7.50%	10.00%	8.50%	42.80%	13.00%	32.80%
Earnings Yield	1.67%	3.35%	2.73%	9.08%	1.46%	-
FCF Yield	0.88%	-0.70%	-5.66%	9.13%	-0.81%	-
Dividend Yield	1.40%	1.35%	1.23%	2.41%	1.23%	-
Payout Ratio	98.12%	56.06%	79.58%	16.70%	5.32%	17.21%
Buyback Yield / Dilution	4.58%	0.49%	-0.70%	-5.53%	-6.03%	-1.26%
Total Shareholder Return	5.98%	1.84%	0.52%	-3.12%	-4.80%	-1.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.